Tag: Human Papillomavirus (HPV)
Catch-Up HPV Doses Effective to Age 21 Against Cervical Neoplasia
But catch-up doses not effective against CIN for women who initiated vaccination at 21 to 26 years
USPSTF Updates Guidance for Cervical Cancer Screening
Cytology recommended every three years from age 21; different screening options from age 30 to 65
HPV Legislation Doesn’t Impact Teen Sexual Behaviors
No substantive or significant associations between HPV legislation and adolescent sexual behaviors
No Higher Risk of Autoimmune Disorders After HPV4 Vaccination
Girls 12 to 17 have no increased risk of autoimmune disorders seven to 60 days after vaccination
HPV Vaccine Eliminates Advanced Skin Cancer in 97-Year-Old
Less than a year following the initial direct-to-tumor vaccine injection, all treated tumors disappeared
Quadrivalent HPV Vaccine Not Tied to Spontaneous Abortion
No evidence of increased risk of spontaneous abortion when inadvertently given before or during pregnancy
HPV Cervical CA Screening Cuts Odds of Later CIN3+ Diagnosis
Use of primary HPV testing results in significantly lower odds of CIN3+ compared with cytology testing
Parents Say Cancer Prevention Best Reason for HPV Vaccination
Findings based on large survey of parents to assess best, worst reasons for vaccination
Older Adults Increasingly Have HPV+ Oropharyngeal Cancers
Regardless of age, favorable survival conferred by an HPV-positive tumor status
NCI Cancer Centers Endorse Goal of Eliminating HPV Cancers
HPV vaccine, screening offer opportunity to prevent 12,000 cervical CAs, 40,000 HPV-linked CAs/year
